About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,591 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,591 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4861-4880 of 6,591 trials

Active not recruitingAutologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)Patients have a type of lymph gland cancer called HD, NHL or lymphoepithelioma (these 3 diseases will be referred to as "Lymphoma").NCT00368082·Houston, Texas and 1 other

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

UnknownInterleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma.It's a single arm, open label prospective study, in which the safety and efficacy of Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T therapy are evaluated…NCT03929107·Hangzhou, Zhejiang

CompletedStudy of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaIn this study, MGCD0103, a new anticancer drug under investigation, is given three times weekly to patients with advanced solid tumors or Non-Hodgkin's Lymphoma.NCT00323934·Baltimore, Maryland and 2 others

WithdrawnTherapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)The purpose of this study is to determine whether sirolimus reduces the symptoms of cutaneous T-cell lymphoma (CTCL) and whether it causes any side effects.NCT01843998·Milwaukee, Wisconsin

WithdrawnChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00004114

WithdrawnCombination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00004039·Newport Beach, California

Active not recruitingStudy of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCLThis is an international, multicenter, multi-arm, phase Ib, model-based dose-escalation study.NCT03240211·Pittsburgh, Pennsylvania and 1 other

UnknownThe Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin LymphomaThis is a single arm, open-label study to evaluate the safety, tolerance and efficacy of CD20 CAR-T Cells in patients with relapsed and refractory B cell non-Hodgkin Lymphoma.NCT04169932·Nanjing, Jiangsu

RecruitingA Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaThe primary purpose of the Phase 1 (Dose Escalation) of this study is to identify the dose-limiting toxicities (DLTs) of Debio 0123 combined with temozolomide (TMZ) (Arm A) and…NCT05765812·Chicago, Illinois and 15 others

TerminatedHigh-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCTPatient stem cells will be mobilized with induction chemotherapy (R)-ICE and G-CSF.NCT00858793·Hamburg

RecruitingA Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin LymphomaThis clinical trial evaluates whether an online cognitive training intervention (Intervention to enhance Cognitive Augmentation and Neuroplasticity \[I-CAN\]), delivered before…NCT07609030·Columbus, Ohio

CompletedAdaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)Participants are invited to take part in this research study because they have relapsed (cancer has come back) or refractory (cancer has not responded to treatment) B-cell…NCT06004167·Boston, Massachusetts and 1 other

RecruitingA Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.The goal of this clinical trial is to evaluate the safety and response of combining Pirtobrutinib and Glofitimab in patients with relapsed MCL.NCT05833763·Parkville, Victoria and 1 other

TerminatedVELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic TherapyThe primary objective of this study is to assess the antitumor activity (in terms of overall response rate - ORR - i.e. sum of complete and partial responses) of bortezomib in…NCT00210392·Bellinzona

UnknownPD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell LymphomaTo observe the safety, tolerability and clinical effects of PD-1 Antibody, Chidamide, Lenalidomide and Etoposide in Relapsed or Refractory NK/T cell Lymphoma.NCT04038411·Zhengzhou, Henan

CompletedA Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell CarcinomaThis is a phase 1, open-label, dose-escalation clinical trial to evaluate the safety of SGN-75 in patients with CD70-positive relapsed or refractory non-Hodgkin lymphoma or…NCT01015911·Birmingham, Alabama and 8 others

CompletedCombination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell LymphomasPre-clinical data and recently published clinical data suggest a synergistic effect between lenalidomide and dexamethasone.NCT00783367·Philadelphia, Pennsylvania

CompletedPhotodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic LeukemiaRATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill cancer cells.NCT00054171·Buffalo, New York

RecruitingA Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesThe researchers are doing this study to test the safety of combining bexarotene with TSEB radiotherapy in people who have a common form of CTCL called mycosis fungoides (MF).NCT05296304·Commack, New York and 2 others

CompletedCombination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaThis phase II trial studies how well combination chemotherapy and ofatumumab work in treating patients with acute lymphoblastic leukemia or lymphoblastic lymphoma.NCT01363128·Houston, Texas

PreviousPage 244 of 330Next